Tradestie Institutional Equity Comparison Engine

BBP vs WDNA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BBP Overall Edge

BBP Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Virtus LifeSci Biotech Products ETF (BBP) driven by superior Options & Structure while WDNA counters with relative strength in Momentum & Technical. Fundamentally, BBP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus WDNA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BBP sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro) against WDNA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BBP N/M vs WDNA N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner WDNA
1Y +30.1% vs +34.1% ยท 52W Pos 70% vs 66%
Options & Structure Winner BBP
UNCLASSIFIED (4th %ile IV) vs UNCLASSIFIED (N/A IV)
BBP NYSE Arca
Virtus LifeSci Biotech Products ETF
Institutional Equity
$99.30
-2.67% 1D
Market Cap N/A
1M Return -0.9%
1Y Return +30.13%
Forward P/E N/M
Unified AI Score
53.0 / 100 HOLD
Tech 37.0 Fund 48.0 Flow 50.0 Mom 60.0
WDNA US Equity
WDNA
Institutional Equity
$21.84
-3.23% 1D
Market Cap N/A
1M Return -2.08%
1Y Return +34.07%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 18.0 Fund 40.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BBP +30.13% WDNA +34.07% Spread: +2.57 pp (WDNA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BBP TTM Op. Margin: N/A WDNA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBP vs WDNA. Trailing 12-month operating profitability (BBP N/A vs WDNA N/A) and valuation multiples (BBP N/M vs WDNA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BBP (3) vs WDNA (0)
Institutional Metric BBP WDNA Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 70% ($74โ€“$110) 66% ($16โ€“$25) Stronger Trend BBP
Beta / 30D Volatility Risk Regime 0.94ฮฒ ยท 30% Vol 1.12ฮฒ ยท 39% Vol Lower Realized Risk BBP
Unified Institutional Score Composite Signal 53.0 / 100 (HOLD) 42.5 / 100 (HOLD) Higher Composite BBP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BBP vs WDNA Buy Guide
BBP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live BBP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
WDNA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live WDNA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BBP nor WDNA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.